Exicure, Inc. XCUR · Stock Open Exicure, Inc. in new tab
Exicure, Inc. Analysis (XCUR)
Is Exicure, Inc. a good investment? Exicure, Inc. (XCUR) is currently trading at 1.15 USD.
Earnings Schedule: Exicure, Inc. is expected to release its next earnings report on Nov. 12, 2026. The market consensus estimate for Forward EPS is -0.77.
Investor FAQ
Does Exicure, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Exicure, Inc.?
Exicure, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Nov. 12, 2026. The company currently has a trailing EPS of -1.31.
Company Profile
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
| Split Date | Split Ratio to 1 |
|---|---|
| June 30, 2022 | 0.03 |
| Aug. 28, 2024 | 1:5 |
Community Discussion